ddhCTP
Based on 1 publication(s) in Google Scholar
ddhCTP is an endogenously produced pyrimidine base analog with a Kd of 17.0 nM for LLDH and an IC50 of 55.8 μM for GAPDH. By inhibiting key metabolic enzymes such as GAPDH, ddhCTP reduces glycolytic flux and shifts metabolic flow toward the pentose phosphate pathway, thereby regulating the redox balance of cells. As a competitive CTP analog, ddhCTP terminates RNA synthesis by flavivirus RdRps and SARS-CoV-2 RdRp, and inhibits Zika virus replication in vivo. ddhCTP can be used in studies related to viral infections, COVID-19 and Zika virus infections.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2279171-34-3
- Formule: C9H14N3O13P3
- Masse moléculaire:465.14
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Publications Citing Use of MedChemExpress (MCE) ddhCTP
MoreVoir tous les produits spécifiques à Isoform DNA/RNA Synthesis
MoreVoir tous les produits spécifiques à Isoform Endogenous Metabolite
More
Activité biologique
ddhCTP (24-96 h) completely abolishes the extracellular levels of phenylacetic acid and 4-hydroxyphenyllactic acid in HEK293 cells expressing wild-type RSAD2[1].
ddhCTP (72 h) modulates the levels of NAD+-dependent enzyme-related metabolites, including decreased taurine levels, increased 2-oxoglutarate levels, increased glyceraldehyde 3-phosphate levels, and increased levels of pentose phosphate pathway intermediates in hiPSC-derived macrophages expressing wild-type RSAD2 after stimulation with LPS and IFN-γ[1].
ddhCTP inhibits the NAD+-dependent forward activity of purified rabbit muscle GAPDH with an IC50 of 55.8 μM, but does not affect the NADH-dependent reverse reaction[1].
ddhCTP (72 μM, 30 s) inhibits the NAD+-dependent activities of purified rabbit muscle LLDH and purified bovine heart MDH, but does not affect the NADH-dependent reverse reaction of LLDH[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 2279171-34-3
-
Masse moléculaire 465.14
-
Formule C9H14N3O13P3
-
SMILES
NC(C=CN1[C@@H]2OC(COP(OP(OP(O)(O)=O)(O)=O)(O)=O)=C[C@H]2O)=NC1=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
EMBO Mol Med
Corneal biomechanical cues mediated by PAI-2: the origin of PM2.5-induced corneal disease. [Abstract]2025 Dec 1. PMID: 41326717
Pureté et documentation
Références
[1]. Honarmand Ebrahimi K, et al. ddhCTP produced by the radical-SAM activity of RSAD2 (viperin) inhibits the NAD+ -dependent activity of enzymes to modulate metabolism. FEBS Lett. 2020;594(10):1631-1644. [Content Brief]
[2]. Ciardullo G, et al. Viral RNA Replication Suppression of SARS-CoV-2: Atomistic Insights into Inhibition Mechanisms of RdRp Machinery by ddhCTP. J Chem Inf Model. 2024;64(5):1593-1604. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
ddhCTP Related Classifications
HY-128788 Related Classifications
Powered by Bioz